Gain of glycosylation: A new pathomechanism of myelin protein zero mutations

Annals of Neurology

Volumn 71, Issue 3, 2012, Pages 427-431

  Prada, Valeria ^a   Passalacqua, Mario ^a   Bono, Maria ^a   Luzzi, Paola ^a   Scazzola, Sara ^a   Nobbio, Lucilla Alessandra ^a   Capponi, Simona ^a   Bellone, Emilia ^a   Mandich, Paola ^a   Mancardi, Gianluigi ^a   Shy, Michael ^a   Schenone, Angelo ^a,b   Grandis, Marina ^a  

^a UNIVERSITY OF GENOA   (Italy)

^b CNR   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

MYELIN; MYELIN PROTEIN ZERO; UNCLASSIFIED DRUG;

ADULT; AMINO ACID ANALYSIS; AMINO TERMINAL SEQUENCE; ARTICLE; CASE REPORT; CELL ADHESION; CONFOCAL MICROSCOPY; CYTOPLASM; DEMYELINATING NEUROPATHY; DISEASE SEVERITY; ELECTROPHYSIOLOGY; EVOKED MUSCLE RESPONSE; FEMALE; GENE SEQUENCE; GLYCOSYLATION; GOLGI COMPLEX; HELA CELL; HEREDITARY MOTOR SENSORY NEUROPATHY; HUMAN; HUMAN CELL; IN VITRO STUDY; INHIBITION KINETICS; MEDICAL HISTORY; MISSENSE MUTATION; MUTATIONAL ANALYSIS; MYELINATED NERVE; NERVE BIOPSY; NEUROLOGIC EXAMINATION; PES EQUINOVARUS; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; PROTEIN MOTIF; SEQUENCE ANALYSIS; WEAKNESS; WESTERN BLOTTING; WILD TYPE;

EID: 84859195166     PISSN: 03645134     EISSN: 15318249     Source Type: Journal    
DOI: 10.1002/ana.22695     Document Type: Article

References (22)

1. Lemke G, Axel R,. Isolation and sequence of a cDNA encoding the major structural protein of peripheral myelin. Cell 1985; 40: 501-508.
2. Eichberg J,. Myelin P0: new knowledge and new roles. Neurochem Res 2002; 27: 1331-1340.
3. Shapiro L, Doyle JP, Hensley P, et al. Crystal structure of the extracellular domain from P0, the major structural protein of peripheral nerve myelin. Neuron 1996; 17: 435-449.
4. Shy ME,. Peripheral neuropathies caused by mutations in the myelin protein zero. J Neurol Sci 2006; 242: 55-66.
5. Shy ME, Jani A, Krajewski K, et al. Phenotypic clustering in MPZ mutations. Brain 2004; 127: 371-384.
6. Grandis M, Vigo T, Passalacqua M, et al. Different cellular and molecular mechanisms for early and late-onset myelin protein zero mutations. Hum Mol Genet 2008; 17: 1877-1889.
7. Wrabetz L, D'Antonio M, Pennuto M, et al. Different intracellular pathomechanisms produce diverse myelin protein zero neuropathies in transgenic mice. J Neurosci 2006; 26: 2358-2368.
8. Filbin MT, Tennekoon GI,. Homophilic adhesion of the myelin P0 protein requires glycosylation of both molecules in the homophilic pair. Ann N Y Acad Sci 1999; 883: 160-167.
9. Sánchez-Laorden BL, Herraiz C, Valencia JC, et al. Aberrant trafficking of human melanocortin 1 receptor variants associated with red hair and skin cancer: steady-state retention of mutant forms in the proximal Golgi. Cell Physiol 2009; 220: 640-654.
10. Ren X, Ostermeyer AG, Ramcharan LT, Zeng Y,. Conformational defects slow Golgi exit, block oligomerization, and reduce raft affinity of caveolin-1 mutant proteins. Mol Biol Cell 2004; 15: 4556-4567.
11. Bolis A, Zordan P, Coviello S, Bolino A,. Myotubularin-related (MTMR) phospholipid phosphatase proteins in the peripheral nervous system. Mol Neurobiol 2007; 35: 308-316.
12. Gabreëls-Festen AA, Hoogendijk JE, Meijerink PH, et al. Two divergent types of nerve pathology in patients with different P0 mutations in Charcot-Marie-Tooth disease. Neurology 1996; 47: 761-765.
13. Fabrizi GM, Taioli F, Cavallaro T, et al. Focally folded myelin in Charcot-Marie-Tooth neuropathy type 1B with Ser49Leu in the myelin protein zero. Acta Neuropathol 2000; 100: 299-304.
14. Cotter L, Ozçelik M, Jacob C, et al. Dlg1-PTEN interaction regulates myelin thickness to prevent damaging peripheral nerve overmyelination. Science 2010; 328: 1415-1418.
15. Vogt G, Chapgier A, Yang K, et al. Gains of glycosylation comprise an unexpectedly large group of pathogenic mutations. Nat Genet 2005; 37: 692-700.
16. Blom N, Sicheritz-Pontén T, Gupta R, et al. Prediction of post-translational glycosylation and phosphorylation of proteins from the amino acid sequence. Proteomics 2004; 4: 1633-1649.
17. Lagueny A, Latour P, Vital A, et al. Peripheral myelin modification in CMT1B correlates with MPZ gene mutations. Neuromuscul Disord 1999; 9: 361-367.
18. Choi BO, Lee MS, Shin SH, et al. Mutational analysis of PMP22, MPZ, GJB1, EGR2 and NEFL in Korean Charcot-Marie-Tooth neuropathy patients. Hum Mutat 2004; 24: 185-186.
19. Mersiyanova IV, Ismailov SM, Polyakov AV, et al. Screening for mutations in the peripheral myelin genes PMP22, MPZ and Cx32 (GJB1) in Russian Charcot-Marie-Tooth neuropathy patients. Hum Mutat 2000; 15: 340-347.
20. Blanquet-Grossard F, Pham-Dinh D, Dautigny A, et al. Charcot-Marie-Tooth type 1B neuropathy: a mutation at the single glycosylation site in the major peripheral myelin glycoprotein P0. Hum Mutat 1996; 8: 185-186.
21. Quarles RH,. Glycoproteins of myelin sheaths. J Mol Neurosci 1997; 8: 1-12.
22. Mandich P, Fossa P, Capponi S, et al. Clinical features and molecular modelling of novel MPZ mutations in demyelinating and axonal neuropathies. Eur J Hum Genet. 2009; 17(9):1129–34. [PubMed: 19293842]